Mary Eapen

Garvan Institute of Medical Research — Australia

Medicine · Health Sciences

73h-index21.5kcitations372works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(272), Acute Lymphoblastic Leukemia research(100), Acute Myeloid Leukemia Research(81), Polyomavirus and related diseases(60), Immune Cell Function and Interaction(36)

Publications371 total

Robust HbF induction and improvement of anemia and hemolysis with base editing in sickle cell disease: Safety and efficacy findings from the ongoing BEACON study
Blood·2025Open Access
Reduced intensity haploidentical bone marrow transplantation in children with severe sickle cell disease (SCD): BMT CTN 1507
Blood·2025Open Access
Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11a
Blood·2025
The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial
Blood·2025
106 Spatial multi-omic characterization of tumor microenvironment heterogeneity in hepatocellular carcinoma
Regular and Young Investigator Award Abstracts·2025· 1 citedOpen Access
Defying age: myth or reality?
Haematologica·2025Open Access
Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]
UNC Libraries·2025Open Access
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
UNC Libraries·2025Open Access
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease
NEJM Evidence·2025· 23 citedOpen Access
Safety and Efficacy of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) for the Treatment of Sickle Cell Disease with Severe Vaso-Occlusive Crises: Results from the Ongoing Phase 1/2 Beacon Study
Transplantation and Cellular Therapy·2025Open Access
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History
New England Journal of Medicine·2025· 9 citedOpen Access
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.
UNC Libraries·2024Open Access
Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises
Blood·2024· 11 cited
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease
Blood Advances·2024· 5 citedOpen Access
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease
Blood Advances·2024· 2 citedOpen Access
One’s expectations for normality
Blood·2024
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study
EClinicalMedicine·2024· 3 citedOpen Access
Choosing donors in clinical practice
Blood·2024
Immunosuppression with post-transplant cyclophosphamide for allogeneic hematopoietic cell transplantation
Haematologica·2024· 1 citedOpen Access
Navigating Treatment Options and Communication in Relapsed Pediatric AML
American Society of Clinical Oncology Educational Book·2024· 8 cited
page 1 of 19Next →

Frequent Co-authors

Mary M. Horowitz(24), Richard E. Champlin(16), John E. Wagner(13), John P. Klein(10), Stephen R. Spellman(10), Éliane Gluckman(9), Mei-Jie Zhang(8), Mark C. Walters(8), Dennis L. Confer(7), Claudio Anasetti(7), Mary J. Laughlin(7), Joanne Kurtzberg(7), Christopher Bredeson(7), Carolyn Katovich Hurley(6), Robert Peter Gale(6), Steven M. Devine(6), Daniel J. Weisdorf(6), Joseph H. Antin(6), Annalisa Ruggeri(6), Brent R. Logan(6)